Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-Bromopyruvate
- PMID: 33445795
- PMCID: PMC7828231
- DOI: 10.3390/ijms22020709
Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-Bromopyruvate
Abstract
3-Bromopyruvic acid (3-BP) is a promising anticancer compound. Two ovary cancer (OC) cell lines, PEO1 and SKOV3, showed relatively high sensitivity to 3-BP (half maximal inhibitory concentration (IC50) of 18.7 and 40.5 µM, respectively). However, the further sensitization of OC cells to 3-BP would be desirable. Delphinidin (D) has been reported to be cytotoxic for cancer cell lines. We found that D was the most toxic for PEO1 and SKOV3 cells from among several flavonoids tested. The combined action of 3-BP and D was mostly synergistic in PEO1 cells and mostly weakly antagonistic in SKOV3 cells. The viability of MRC-5 fibroblasts was not affected by both compounds at concentrations of up to 100 µM. The combined action of 3-BP and D decreased the level of ATP and of dihydroethidium (DHE)-detectable reactive oxygen species (ROS), cellular mobility and cell staining with phalloidin and Mitotracker Red in both cell lines but increased the 2',7'-dichlorofluorescein (DCFDA)-detectable ROS level and decreased the mitochondrial membrane potential and mitochondrial mass only in PEO1 cells. The glutathione level was increased by 3-BP+D only in SKOV3 cells. These differences may contribute to the lower sensitivity of SKOV3 cells to 3-BP+D. Our results point to the possibility of sensitization of at least some OC cells to 3-BP by D.
Keywords: 3-bromopyruvate; anthocyanidins; delphinidin; glycolytic inhibitors; ovarian cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Boussios S., Karihtala P., Moschetta M., Abson C., Karathanasi A., Zakynthinakis-Kyriakou N., Ryan J.E., Sheriff M., Rassy E., Pavlidis N. Veliparib in ovarian cancer, a new synthetically lethal therapeutic approach. Investig. New Drugs. 2020;38:181–193. doi: 10.1007/s10637-019-00867-4. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
